1. Home
  2. HROW vs SEI Comparison

HROW vs SEI Comparison

Compare HROW & SEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • SEI
  • Stock Information
  • Founded
  • HROW 1998
  • SEI 2014
  • Country
  • HROW United States
  • SEI United States
  • Employees
  • HROW N/A
  • SEI N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • SEI
  • Sector
  • HROW Health Care
  • SEI
  • Exchange
  • HROW Nasdaq
  • SEI NYSE
  • Market Cap
  • HROW 1.1B
  • SEI 1.2B
  • IPO Year
  • HROW N/A
  • SEI 2017
  • Fundamental
  • Price
  • HROW $34.93
  • SEI $31.40
  • Analyst Decision
  • HROW Strong Buy
  • SEI Strong Buy
  • Analyst Count
  • HROW 7
  • SEI 8
  • Target Price
  • HROW $61.83
  • SEI $43.71
  • AVG Volume (30 Days)
  • HROW 368.3K
  • SEI 1.3M
  • Earning Date
  • HROW 08-06-2025
  • SEI 07-23-2025
  • Dividend Yield
  • HROW N/A
  • SEI 1.54%
  • EPS Growth
  • HROW N/A
  • SEI N/A
  • EPS
  • HROW N/A
  • SEI 0.50
  • Revenue
  • HROW $212,858,000.00
  • SEI $371,533,000.00
  • Revenue This Year
  • HROW $44.89
  • SEI $65.83
  • Revenue Next Year
  • HROW $38.22
  • SEI $35.50
  • P/E Ratio
  • HROW N/A
  • SEI $61.95
  • Revenue Growth
  • HROW 53.49
  • SEI 33.59
  • 52 Week Low
  • HROW $20.85
  • SEI $10.96
  • 52 Week High
  • HROW $59.23
  • SEI $39.03
  • Technical
  • Relative Strength Index (RSI)
  • HROW 70.24
  • SEI N/A
  • Support Level
  • HROW $30.81
  • SEI N/A
  • Resistance Level
  • HROW $33.27
  • SEI N/A
  • Average True Range (ATR)
  • HROW 1.37
  • SEI 0.00
  • MACD
  • HROW 0.09
  • SEI 0.00
  • Stochastic Oscillator
  • HROW 88.78
  • SEI 0.00

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution. Its segment include Solaris Power Solutions and Solaris Logistics Solutions. It derives maximum revenue from Solaris Logistics Solutions segment.

Share on Social Networks: